Computational and Population-Based HLA Permissiveness to HIV Drug Resistance-Associated Mutations

Area of Science:

• Immunology
• Virology
• Computational Biology
• Genetics

Background:

• Human leukocyte antigen (HLA) presentation of Human Immunodeficiency Virus (HIV) peptides to CD8+ cytotoxic T-cells (CTLs) is crucial for controlling viral pathogenesis.
• HIV's ability to mutate allows immune evasion and antiretroviral drug resistance, posing a challenge to treatment and control.
• Understanding the interplay between HIV evolution, drug resistance, and host immune response is vital for effective therapeutic strategies.

Purpose of the Study:

• To computationally assess the impact of HIV drug resistance-associated mutations (RAMs) on the binding affinity of HIV-1 peptides to prevalent human leukocyte antigen (HLA) alleles.
• To investigate population-specific variations in RAM emergence influenced by HLA allele frequencies.
• To explore the potential for HLA alleles to shape the evolutionary trajectory of HIV drug resistance.

Main Methods:

• Utilized a computational approach to model peptide-HLA binding.
• Analyzed HIV-1 subtype B and C peptides containing RAMs.
• Assessed binding to a panel of the most common HLA alleles in US, European, and South African populations.

Main Results:

• Predicted specific RAMs that may be favored in different populations based on HLA allele prevalence.
• Identified an under-representation of the Y181C mutation in individuals with HLA-B*57:01, consistent with computational predictions.
• Demonstrated the potential relevance of computational modeling in understanding immune escape and drug resistance dynamics.

Conclusions:

• Developed a conceptual framework to analyze the influence of HLA alleles on the emergence of HIV RAMs.
• Highlighted population-specific immune pressures that may drive HIV evolution.
• Provided insights into the complex relationship between host genetics, viral mutations, and treatment outcomes in HIV infection.